Serum transferrin receptor concentration in patients with anemias and polycythemias was determined. The mean normal value was 258±82 ng/ml. Comparing with normal values, the higher values were obtained in patients with iron deficiency anemia, autoimmune hemolytic anemia, and polycythemias, while the lower values were obtained in patients with aplsatic anemia. During treatments of patients with iron deficiency anemia and autoimmunehemolytic anemia, serial change of serum receptor was pararelled with that of peripheral reticulocyte counts, suggesting that the circulating receptor values may reflect the activity of bone marrowerythropoiesis. The immunoreactive receptor was migrated at the position of (Xi -globulin by agarose gel electrophoresis and the isoelectric point(pl) was 3.57 by isoelectric focusing. SDS-polyaerylamide gel electrophorogram of various patients' sera revealed that the autoradiographed band was migrated at the molecular weight of 1 10,000 daltons in the non-reducing condition and 46,000 and 23,000 daltons in the reducing condition. These bands were also capable of binding to 1 I-labelled diferric transferrin. The proposed model of circulating transferrin receptor may be the nicked dimers of 55 ,000 daltons in which inter-and intra-disulfide bridges were present.
It is generally accepted that erythrocyte progenitor cells require more iron for cell proliferation and hemoglobin synthesis and express significant amount of transferrin receptors on the cell surface1 2\ The receptor binds serum diferric transferrin3^and transferred to acidosomes, where inorganic iron is released into the cytosol and the remaining ligand and receptor is recycled back to the cell surface. During this recycling process, transferrin receptor was found to be externalized4\
Recently we established a quantitative methodfor measuring immunoreactive transferrin receptor by using two different monoclonal antibodies, 0KT9 and B3/255) and found that serum transferrin receptor concentration in patients with anemias may reflect the bone marrow erythropoiesis6-.
In the present paper, we describe the distribution and the molecular form of circulating transferrin receptors in patients with anemias and polycythemias.
MATERIALS AND METHODS
1. Blood samples Serumsamples were obtained from 92 normal subjects (38 males, 54 females), 41 patients with iron deficiency anemia, 5 with autoimmune hemolytic anemia, 5 with aplastic anemia, and 6 with polycythemia (3 primary and 3 secondary).
All serum samples were stored at -20°C until use. 
Sandwich radioimmunoassay

1) Agarose gel electrophoresis
Three microlitter of serum sample was electrophoresed on horizontal gels (3 mmthick, 5 x 10 cm long) in 0.05M barbiturate buffer, pH 8.6 at 100 V for 2 hr at room temperature. After electrophoresis, the proteins in the gel were electrophretically transferred to a nitrocellulose paper (Schleicher and Schuell, BA 85, West Germany) using Trans-Blot Cell (Bio-Rad, U.S.A.) at 400 mA for 3 hr in 0.7% acetic acid by the method ofTowbin et al10). The blots were blocked with PBS containing 3% BSA, rinsed with PBS and incubated for 3 hr at room temperature with 1311-labelled OKT9. Following extensive washing with PBS, the blots were dried and exposed to Kodak XAR-5 film for 3 hr. 2.0 to 6.0, and electrophoresed at 400V for 4 hr at 4°C. Following electrophoresis, the proteins in the gel were transferred to a nitrocellulose paper and the blots were treated as described above, and exposed to Kodak XAR-5 film for 3 hr.
3) SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGEwas carried out on 5.6% polyacrylamide gel in 1% sodium dodecyl sulfate(SDS) described by Fairbanks et al12\ Serum samples were prepared for electrophoresis as follows: 3 /xl of serum was added 3 jxl of 20 mMTris-HCl, 50% glycerine, 2% SDS, 10% 2-mercaptoethanol, pH 8.0 (2x sample buffer).
The solution was immersed for 30 min at 60°C in the presence or absence of 5% of 2-mercaptoethanol and 6 jul was loaded into each of 10 slots of the slab gel and ran at 60 mA for 3 hr. Following electrophoresis, the proteins in the unstained gels were electrophoretically transferred to a nitrocellulose paper in Trans-Blot Cell at 80 mA for 12 hr, using a transfer buffer consisting of 25 mMTris, 192 mMglycine, pH 8.3. The blots were blocked with PBS containing 3% BSA, rinsed with PBS, and incubated for 3 hr at room temperature with 131 I-labelled 0KT9 or 131 Mabelled diferric transferrin. Following extensive washing with PBS, the nitrocellulose blots were exposed to Kodak XAR-5 film for 3 hr.
RE SULTS 1. Distribution of serum transferrin receptor levels in normal subjects and patients with various anemias and polycythemias.
Serum transferrin receptor levels in normal subjects and patients with various anemias and polycythemias are shown in Fig. 1 ng/ml), autoimmune hemolytic anemia (1,426± 1,079 ng/ml), primary polycythemia (800± 125 ng/ml), and secondary polycythemia (l,033±
208 ng/ml), while lower values were obtained in patients with aplastic anemia (182±39 ng/ml). Effect of the treatment with oral iron supplementation in patients with iron deficiency anemia and that with prednisolone in patients with autoimmune hemolytic anemia were shown in Fig. 2 . The iron supplementation increased serum transferrin receptor value up to l,016±326 ng/ml and thereafter returned to normla range (Fig. 2-A) . In patients with autoimmune hemolytic anemia, the significant decrease of serum transferrin receptor levels were observed after effective therapy with prednisolone ( Fig. 2-B) . Serial changes of serum transferrin receptor were pararelled with those of peripheral reticulocyte counts.
Molecular form of serum transferrin receptor
An electrophoretic mobility of circulating immunoreactive transferrin receptor was examined by agarose gel electrophoresis and isoelectric focusing (Fig. 3) . By agarose gel electrophoresis, a single band migrated at ax-globulin region was identified by 131 1-labelled anti-transferrin receptor monoclonal antibody, 0KT9 (Fig. 3-A) . The pi of the immunoreactive band was 3.57 ( Fig.  3-B) .
By SDS-PAGE/immunotransblotting by 131I-OKT9, a 110,000 dalton protein was visualized in the absence of 2-mercaptoethanol and two distinguished bands corresponding 46,000 and 23,000 dalton bands were visualized in the presence of 2-mercaptoethanol (Fig. 4-A) . These three bands were capable binding to 131 1-labelled diferric transferrin (Fig. 4-B) . By loading 6 different serum samples on SDS-polyacrylamide gel electrophoresis under reducing condition, all the samples showed the two bands corresponding 46,000 and 23,000 daltons (Fig. 5) . Under this electrophoretic conditions, there is no difference between these serum transferrin receptors derived from various anemias and polycythemias. DISCUSSION We describe here the evidence that immunoreactive transferrin receptor could be detected in human serum and the value may reflect the bone marrow erythropoiesis because of a good correlation between these values and peripheral reticulocyte counts.
Since Jandl and Katz13) first reported the presence of transferrin receptors on reticulocyte surface, erythrocyte progenitor cells are thought to be main distributed cells of transferrin receptors in the body. The receptor expression on reticulocytes and erythrocyte progenitor cells are thought to be regulated by the equilibrium between its recycling and synthesis14'15\ The receptor mRNA synthesis is increased with the addition of iron deficient serum and iron chelating agents in vitro16\
It is likely that the expression of transferrin receptors of reticulocytes in iron deficiency anemia possess more receptors than usual. In addition, Pan and Johnstone4^described that the receptor of reticulocytes were shed and released into the medium. Therefore the measuring the shed circulating transferrin receptor in the serum may be a practically efficient way for estimation of the erythrocyte transferrin receptor turnover. As shown in Fig. 1 , the higher levels of receptor in iron deficiency anemia, autoimmune hemolytic anemia, and polycythemias and the lower value in aplastic anemia are reflection of the activity of erythropoiesis in the bone marrow. The serial changes of serum transferrin receptor values before and after successive treatment (Fig. 2 ) also suggested that increased or decreased serum transferrin receptors in iron deficiency anemia and autoimmune hemolytic anemia reflect the activity of erythron.
Despite such an apparent demonstration of the circulating transferrin receptor in serum, the precise mechanism of its entry into serum is presently obscure. It is consistent the only one major band which is migrated at ax-globulin and pi 3.57 was detected.
Using SDS-PAGE/immunotransblotting, a single band which corresponds 110,000 daltons under the non-reducing condition. This molecular weight is approximately compatible to the band which we reported pre- condition, suggesting that several inter-and intradisulfide bridges were present. Taking together that these three bands were capable of binding to diferric transferrin, the possible circulating transferrin receptor constitutes the structure as shown in Fig. 6 of disulfide bridges and other fragments which is not reactive to 0KT9 antibody.
In conclusion, the measurement of circulating transferrin receptor in patients with various anemias and polycythemias may be an useful newindex for estimating bone marrowerythropoiesis.
